All but two patients with an initial diagnosis of HER2pos breast cancer fell into the high group, indicating that this combined analysis of the numbers of HER2+EVs per μl and HER2 expression levels correlates with high HER2 expression in breast cancer tissue. The gene discussed is ERBB2; the disease is breast carcinoma.